Abstract
Flow cytometry is a diagnostic technique capable of distinguishing cells by their size, internal complexity, and antigen repertoire (phenotype) with the use of monoclonal antibodies conjugated with fluorescent dyes. Nowadays, flow cytometry has become a highly specific and fully reproducible method for the diagnosis of hematological malignancies. Flow cytometry allows for the analysis of any type of sample prepared as a single cell suspension, e.g., blood, bone marrow, cerebrospinal fluid, as well as homogenized solid tissues like lymph nodes. The detailed phenotypic features of the analyzed cells depend on the number of simultaneously used monoclonal antibodies, which is in turn dependent on the flow cytometer specification. Flow cytometric assays, particularly immunophenotyping, have broad clinical applications, especially in the diagnostics of hematological malignancies (e.g., acute lymphoblastic leukemia—ALL, acute myeloid leukemia—AML and chronic lymphoproliferative disorders—CLPD), based on precise determination of the lineage, maturation stage and phenotypic aberrancies of tumor versus normal/reactive cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Asnafi V, Beldjord K, Boulanger E, Comba B, Le Tutour P, Estienne MH, Davi F, Landman-Parker J, Quartier P, Buzyn A, Delabesse E, Valensi F, Macintyre E (2003) Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood 101:2693–2703
Barrena S, Almeida J, Del Carmen Garcia-Macias M, Lopez A, Rasillo A, Sayagues JM, Rivas RA, Gutierrez ML, Ciudad J, Flores T, Balanzategui A, Caballero MD, Orfao A (2011) Flow cytometry immunophenotyping of fine-needle aspiration specimens: utility in the diagnosis and classification of non-Hodgkin lymphomas. Histopathology 58:906–918. doi:10.1111/j.1365-2559.2011.03804.x
Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van’t Veer MB (1995) Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 9:1783–1786
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1985) Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 103:620–625
Foss FM, Zinzani PL, Vose JM, Gascoyne RD, Rosen ST, Tobinai K (2011) Peripheral T-cell lymphoma. Blood 117:6756–6767
Givan AL (2004) Flow cytometry: an introduction. Methods Mol Biol 263:1–32
Gorczyca W, Weisberger J, Liu Z, Tsang P, Hossein M, Wu CD, Dong H, Wong JY, Tugulea S, Dee S, Melamed MR, Darzynkiewicz Z (2002) An approach to diagnosis of T-cell lymphoproliferative disorders by flow cytometry. Cytometry 50:177–190
Greaves MF, Janossy G, Peto J, Kay H (1981) Immunologically defined subclasses of acute lymphoblastic leukemia in children: their relationship to presentation features and prognosis. Br J Hematol 48:179–197
Herzenberg LA, Parks D, Sahaf B, Perez O, Roederer M, Herzenberg LA (2002) The history and future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford. Clin Chem 48:1819–1827
Jaffe ES (2009) The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematol Am Soc Hematol Educ Program 113:523–531
Karube K, Aoki R, Nomura Y, Yamamoto K, Shimizu K, Yoshida S, Komatani H, Sugita Y, Ohshima K (2008) Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases. Pathol Int 58:89–97
Maecker HT, Trotter J (2006) Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A 69:1037–1042
Mahnke YD, Roederer M (2007) Optimizing a multicolor immunophenotyping assay. Clin Lab Med 27:469–485
Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW, Hamblin TJ, Staudt LM, Oscier DG (2004) ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 363:105–111
Orfao A, Ortuño F, de Santiago M, Lopez A, San Miguel J (2004) Immunophenotyping of acute leukemias and myelodysplastic syndromes. Cytometry A 58:62–71
Orfao A, Lopez A, Flores J, Almeida J, Vidriales BM, Perez J, Kneba M, Macintyre E, Parreira A, Richards S, Szczepański T, Trka J, van der Velden VHJ, van Dongen JJM (2006) Diagnosis of haematological malignancies: new applications for flow cytometry. Hematology 5:6–13 (Education Program of the 11th Congress of the European Hematology Association, Amsterdam, The Netherlands June 15–18, 2006)
Palumbo GA, Parrinello N, Fargione G, Cardillo K, Chiarenza A, Berretta S, Conticello C, Villari L, Di Raimondo F (2009) CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia. Leuk Res 33:1212–1216
Porwit-MacDonald A, Björklund E, Lucio P, van Lochem EG, Mazur J, Parreira A, van den Beemd MW, van Wering ER, Baars E, Gaipa G, Biondi A, Ciudad J, van Dongen JJ, San Miguel JF, Orfao A (2000) BIOMED-1 concerted action report: flow cytometric characterization of CD7 + cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL). Leukemia 14:816–825
Radcliff G, Jaroszeski MJ (1998) Basics of flow cytometry. Methods Mol Biol 91:1–24
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) WHO classification of tumours of haematopoietic and lymphoid tissues (4th ed). IARC, Lyon, France
Szczepański T, Orfao A, van der Velden VHJ, San Miguel JF, van Dongen JJ (2001) Minimal residual disease in leukaemia patients. Lancet Oncol 2:409–417
Szczepański T, van der Velden VHJ, van Dongen JJM (2003) Classification systems for acute and chronic leukaemias. Best Pract Res Clin Haematol 16:561–582
Szczepański T, van der Velden VHJ, van Dongen JJM (2006) Flow-cytometric immunophenotyping of normal and malignant lymphocytes. Clin Chem Lab Med 44:775–796
Van Wering ER, van Lochem EG, Leenders M, van der Sluijs-Gelling AJ, Wind H, Gratama JW, Kraan J, Preijers FW (2004) Three-color flowcytometric analysis of mature and immature hematological malignancies. A guideline of the Dutch Foundation for Immunophenotyping of Hematological Malignancies (SIHON). J Biol Regul Homeost Agents 18:313–326
Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellström-Lindberg E, Tefferi A, Bloomfield CD (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5):937–951
Wood B (2007) Myeloid malignancies: myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia. Clin Lab Med 27:551–575
Zola H, Swart B, Banham A, Barry S, Beare A, Bensussan A, Boumsell L, Buckley CD, Bühring HJ, Clark G, Engel P, Fox D, Jin BQ, Macardle PJ, Malavasi F, Mason D, Stockinger H, Yang X, Stockinger H, Yang X (2007) CD molecules 2006—human cell differentiation molecules. J Immunol Methods 319:1–5
Zucchetto A, Bomben R, Dal Bo M, Bulian P, Benedetti D, Nanni P, Del Poeta G, Degan M, Gattei V (2006) CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance. Leukemia 20:523–525
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sędek, Ł. et al. (2012). Flow Cytometric Immunophenotyping as Diagnostic Tool of Hematopoietic Malignancies. In: Witt, M., Dawidowska, M., Szczepanski, T. (eds) Molecular Aspects of Hematologic Malignancies. Principles and Practice. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29467-9_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-29467-9_9
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-29466-2
Online ISBN: 978-3-642-29467-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)